Epidemiology and risk factors of venous thromboembolism

被引:100
作者
Ageno, Walter
Squizzato, Alessandro
Garcia, David
Imberti, Davide
机构
[1] Univ Insubria, Dept Clin Med, Varese, Italy
[2] Univ New Mexico, Dept Med, Albuquerque, NM USA
[3] Osped Piacenza, Dept Med, Piacenza, Italy
关键词
venous thromboembolism; epidemiology; risk factors; prophylaxis;
D O I
10.1055/s-2006-951293
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Venous thromboembolism (VTE) is a common disorder that can affect apparently healthy as well as hospitalized patients. The actual incidence and prevalence of this disease are difficult to estimate because of its often silent nature. The clinical relevance of VTE is highlighted by the important rates of recurrence and mortality. The individual risk of VTE varies as a result of a complex interaction between congenital and transient or permanent acquired risk factors. Risk factors can be either intrinsic (e.g., age, obesity, history of VTE, or thrombophilia) or disease related (e.g., surgical procedures and medical disorders such as cancer, heart failure, or acute respiratory failure). The presence or absence of specific risk factors may play an important role in decisions about the type (and duration) of thromboprophylaxis/anticoagulation to be used.
引用
收藏
页码:651 / 658
页数:8
相关论文
共 77 条
[1]   Obesity: risk of venous thrombosis and the interaction with coagulation factor levels and oral contraceptive use [J].
Abdollahi, M ;
Cushman, M ;
Rosendaal, FR .
THROMBOSIS AND HAEMOSTASIS, 2003, 89 (03) :493-498
[2]   A POPULATION-BASED PERSPECTIVE OF THE HOSPITAL INCIDENCE AND CASE-FATALITY RATES OF DEEP-VEIN THROMBOSIS AND PULMONARY-EMBOLISM - THE WORCESTER DVT STUDY [J].
ANDERSON, FA ;
WHEELER, HB ;
GOLDBERG, RJ ;
HOSMER, DW ;
PATWARDHAN, NA ;
JOVANOVIC, B ;
FORCIER, A ;
DALEN, JE .
ARCHIVES OF INTERNAL MEDICINE, 1991, 151 (05) :933-938
[3]  
[Anonymous], J THROMB HAEMOST S
[4]  
ATRASH HK, 1990, OBSTET GYNECOL, V76, P1055
[5]   Fatal pulmonary embolism in hospitalised medical patients [J].
Baglin, TP ;
White, K ;
Charles, A .
JOURNAL OF CLINICAL PATHOLOGY, 1997, 50 (07) :609-610
[6]  
Bazzan M, 2001, THROMB RES, V101, pV175
[7]  
BENTAL O, 1989, THROMB HAEMOSTASIS, V61, P50
[8]   Arginase reciprocally regulates nitric oxide synthase activity and contributes to endothelial dysfunction in aging blood vessels [J].
Berkowitz, DE ;
White, R ;
Li, DC ;
Minhas, KM ;
Cernetich, A ;
Kim, S ;
Burke, S ;
Shoukas, AA ;
Nyhan, D ;
Champion, HC ;
Hare, JM .
CIRCULATION, 2003, 108 (16) :2000-2006
[9]   Malignancies, prothrombotic mutations, and the risk of venous thrombosis [J].
Blom, JW ;
Doggen, CJM ;
Osanto, S ;
Rosendaal, FR .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (06) :715-722
[10]  
Bounameaux H, 1996, BMJ-BRIT MED J, V312, P284